KATIE LLOYD

Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family CENTURY, FL NPI 1780187682

General Payments — all program years on this page

$949.70

  • Category: General Payments
  • Program years: PY2021–2024
  • Record count: 36
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $397.30 across 19 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $397.3019

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Janssen Pharmaceuticals, Inc $164.898
ABBVIE INC. $58.862
Indivior Inc. $49.303
Braeburn Inc. $42.982
Teva Pharmaceuticals USA, Inc. $35.072
Vanda Pharmaceuticals Inc. $32.201
ITI, Inc. $14.001

By program year

Program yearAmountRecords
2021 $192.263
2022 $131.194
2023 $228.9510
2024 $397.3019

Records — PY2024 (19)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1077955968 Janssen Pharmaceuticals, Inc $19.54 07/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1077955970 Janssen Pharmaceuticals, Inc $23.89 05/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1077955972 Janssen Pharmaceuticals, Inc $19.55 09/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1077955974 Janssen Pharmaceuticals, Inc $21.50 06/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1077955976 Janssen Pharmaceuticals, Inc $19.55 11/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1077955978 Janssen Pharmaceuticals, Inc $20.60 11/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1077955980 Janssen Pharmaceuticals, Inc $19.78 09/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1077955982 Janssen Pharmaceuticals, Inc $20.48 02/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107548158 ABBVIE INC. $32.15 10/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107548160 ABBVIE INC. $26.71 10/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125616314 Braeburn Inc. $16.47 02/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125616316 Braeburn Inc. $26.51 07/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133954666 Vanda Pharmaceuticals Inc. $32.20 12/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143535036 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $14.00 03/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1144560747 Indivior Inc. $14.63 09/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1144560749 Indivior Inc. $17.29 10/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1144560751 Indivior Inc. $17.38 12/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151474967 Teva Pharmaceuticals USA, Inc. $14.28 01/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151475001 Teva Pharmaceuticals USA, Inc. $20.79 03/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.